Publicaciones

Publicaciones

A continuación, te presentamos un listado de las publicaciones en las que hemos participado organizadas por año

Монтажная область 13

+

Монтажная область 4
  • 2021
  • 2020
  • 2019
  • 2018
  • 2017
  • 2016
  • 2015
  • 2014
  • 2013
  • 2012
  • 2011
  • 2010
  • 2009
  • 2008
  • 2006
  • 2005

1. Francisco José Álvarez García, María José Cilleruelo Ortega, Javier Álvarez Aldeán, María Garcés-Sánchez, Nuria García Sánchez, Elisa Garrote Llanos, Ángel Hernández Merino, Antonio Iofrío de Arce, Abián Montesdeoca Melián, María Luisa Navarro Gómez, Jesús Ruiz-Contreras, en representación del Comité Asesor de Vacunas de la Asociación Española de Pediatría (CAV-AEP). Immunisation schedule of the Pediatric Spanish Association: 2021 recommendations. PMID: 33419517 DOI: 10.1016/j.anpedi.2020.10.002

2. Jacob Bornstein, Surita Roux, Lone Kjeld Petersen, Li-Min Huang, Simon R Dobson, Punnee Pitisuttithum, Javier Diez-Domingo, Andrea Schilling, Hany Ariffin, Richard Tytus, Richard Rupp, Shelly Senders, Eli Engel, Daron Ferris, Yae-Jean Kim, Young Tae Kim, Zafer Kurugol, Oliver Bautista, Katrina M Nolan, Sandhya Sankaranarayanan, Alfred Saah, Alain Luxembourg. Three-Year Follow-up of 2-Dose Versus 3-Dose HPV Vaccine. DOI: 10.1542/peds.2019-4035. Epub 2020 Dec 22.

3. Ainara Mira-Iglesias, F. Xavier López-Labrador, Javier García-Rubio, Beatriz Mengual-Chuliá, Miguel Tortajada-Girbés, Joan Mollar-Maseres, Mario Carballido-Fernández, Germán Schwarz-Chavarri, Joan Puig-Barberà and Javier Díez-Domingo. Influenza Vaccine Effectiveness and Waning Effect in Hospitalized Older Adults. Valencia Region, Spain, 2018/2019 Season. Int. J. Environ. Res. Public Health 2021. DOI: 10.3390/ijerph18031129 

4. Antonio Carmona, Cintia Muñoz-Quiles, Anke Stuurman, Alexandre Descamps, Ainara Mira-Iglesias, Laurence Torcel-Pagnon, Javier Díez-Domingo. Challenges and Adaptation of a European Influenza Vaccine Effectiveness Study Platform in Response to the COVID-19 Emergence: Experience from the DRIVE Project. PMID: 33504081 DOI: 10.3390/ijerph18031058

5. Francesco Gesualdo, Margherita Daverio, Laura Palazzani, Dimitris Dimitriou, Javier Diez-Domingo, Jaime Fons-Martinez, Sally Jackson, Pascal Vignally, Caterina Rizzo, Alberto Eugenio Tozzi. Digital tools in the informed consent process: a systematic review. BMC Med Ethics. 2021 Feb 27;22(1):18. DOI: 10.1186/s12910-021-00585-8.

6. Simon de LusignanUy HoangHarshana Liyanage, Manasa TripathyJulian SherlockMark JoyFilipa Ferreira, Javier Diez-DomingoTristan Clark. Using Point of Care Testing to estimate influenza vaccine effectiveness in the English primary care sentinel surveillance network. PMID: 33705452. DOI: 10.1371/journal.pone.0248123

7. i-CONSENT Consortium. Guidelines for tailoring the informed consent process in clinical studies. DOI: 10.5281/zenodo.4563938

8. Beatriz Mengual-Chuliá, Andrés Alonso-Cordero, Laura Cano, M Del Mar Mosquera, Patricia de Molina, Roser Vendrell, Mariana Reyes-Prieto, Mireia Jané, Nuria Torner, Ana Isabel Martínez, Jordi Vila, Javier Díez-Domingo, M Ángeles Marcos, F Xavier López-Labrador, Valencia Hospital Network for the Study of Influenza and Respiratory Viruses Disease (VAHNSI). Surveillance of Influenza A resistance to polymerase complex inhibitors by whole genome analysis, 2016-17, 2017-18 and 2018-19 Seasons, Eastern Spain. 2021 Mar 29;AAC.02718-20. DOI: 10.1128/AAC.02718-20.

9. Estelle Méroc, Janeri Fröberg, Timea Almasi, Brita Askeland Winje, Alejandro Orrico-Sánchez, Anneke Steens, Scott A. McDonald, Kaatje Bollaerts & Mirjam J. Knol. European data sources for computing burden of (potential) vaccine-preventable diseases in ageing adults. Méroc et al. BMC Infectious Diseases (2021) 21:345 DOI: 10.1186/s12879-021-06017-7

10. Cintia Muñoz-Quiles, Javier Díez-Domingo, Luis Acedo, Víctor Sánchez-Alonso and Rafael J. Villanueva. On the Elimination of Infections Related to Oncogenic Human Papillomavirus: An Approach Using a Computational Network ModelViruses 2021, 13(5), 906; https://doi.org/10.3390/v13050906

1. Anibal García-Sempere, Alejandro Orrico-Sánchez, Cintia Muñoz-Quiles, Isabel Hurtado, Salvador Peiró, Gabriel Sanfélix-Gimeno, Javier Diez-Domingo. Data resource profile: the Valencia health system integrated database (VID). International Journal of Epidemiology, dyz266, Published: 16 January 2020. DOI:10.1093/ije/dyz266

2. Azzari C, Diez-Domingo J, Eisenstein E, Faust SN, Konstantopoulos A, Marshall GS, Rodrigues F, Schwarz TF, Weil-Olivier C. Experts’ opinion for improving global adolescent vaccination rates: a call to action. Eur J Pediatr. 2020 Feb 18. DOI: 10.1007/s00431-019-03511-8.

3. Wang X, Li Y, O’Brien KL, Madhi SA, Widdowson MA, Byass P, Omer SB, Abbas Q, Ali A, Amu A, Azziz-Baumgartner E, Bassat Q, Abdullah Brooks W, Chaves SS, Chung A, Cohen C, Echavarria M, Fasce RA, Gentile A, Gordon A, Groome M, Heikkinen T, Hirve S, Jara JH, Katz MA, Khuri-Bulos N, Krishnan A, de Leon O, Lucero MG, McCracken JP, Mira-Iglesias A, Moïsi JC, Munywoki PK, Ourohiré M, Polack FP, Rahi M, Rasmussen ZA, Rath BA, Saha SK, Simões EA, Sotomayor V, Thamthitiwat S, Treurnicht FK, Wamukoya M, Yoshida LM, Zar HJ, Campbell H, Nair H; Respiratory Virus Global Epidemiology Network. Global burden of respiratory infections associated with seasonal influenza in children under 5 years in 2018: a systematic review and modelling study. Lancet Glob Health. 2020 Feb 20. pii: S2214-109X(19)30545-5. DOI: 10.1016/S2214-109X(19)30545-5.

4. Orrico-Sánchez A, López-Lacort M, Muñoz-Quiles C, Sanfélix-Gimeno G, Díez-Domingo J. Epidemiology of schizophrenia and its management over 8-years period using real-world data in Spain.BMC Psychiatry. 2020 Apr 5;20(1):149. DOI: 10.1186/s12888-020-02538-8.

5. Arnedo-Pena A, Puig-Barberà J, Artero-Civera A, Romeu-Garcia MA, Meseguer-Ferrer N, Fenollosa-Amposta C, Vizcaino-Batllés A, Silvestre-Silvester E, Pac-Sa MR, Segura-Navas L, Dubón MA, Fabregat-Puerto J, Bellido-Blasco JB. Atopic dermatitis incidence and risk factors in young adults in Castellon (Spain): A prospective cohort study. Allergol Immunopathol (Madr). 2020 May 8. pii: S0301-0546(20)30062-8. DOI: 10.1016/j.aller.2020.01.004.

6. Pascal Crépey , Esther Redondo , Javier Díez-Domingo , Raúl Ortiz de Lejarazu , Federico Martinón-Torres , Ángel Gil de Miguel , Juan Luis López-Belmonte , Fabián P. Alvarez , Hélène Bricout , Míriam Solozabal. From trivalent to quadrivalent influenza vaccines: Public health and economic burden for different immunization strategies in Spain. Published: May 21, 2020. https://doi.org/10.1371/journal.pone.0233526

7. Sam Martin, Eliz Kilich, Sara Dada, Per Egil Kummervold, Chermain Denny, Pauline Paterson, Heidi J Larson. Vaccines for pregnant women…?! Absurd» – Mapping maternal vaccination discourse and stance on social media over six months. Vaccine. 2020 Aug 9. S0264-410X(20)31016-1. DOI: 10.1016/j.vaccine.2020.07.072.

8. Anke L Stuurman, Kaatje Bollaerts, Maria Alexandridou, Jorne Biccler, Javier Díez Domingo, Hanna Nohynek, Caterina Rizzo, Topi Turunen, Margarita Riera-Montes, DRIVE Public Partners. Vaccine effectiveness against laboratory-confirmed influenza in Europe – Results from the DRIVE network during season 2018/19. PMID: 32778474. DOI: 10.1016/j.vaccine.2020.07.063

9. Mónica López-Lacort, Alejandro Orrico-Sánchez, Miguel Ángel Martínez-Beneito, Cintia Muñoz-Quiles and Javier Díez-Domingo. Spatio-temporal impact of self-financed rotavirus vaccination on rotavirus and acute gastroenteritis hospitalisations in the Valencia region, Spain. BMC Infectious Diseases (2020) 20:656. DOI: 10.1186/s12879-020-05373-0

10. Cintia Muñoz-Quiles, Mónica López-Lacort, Javier Díez-Domingo and Alejandro Orrico-Sánchez. Herpes zoster risk and burden of disease in immunocompromised populations: a population-based study using health system integrated databases, 2009–2014. BMC Infectious Diseases (2020) 20:905. DOI: 10.1186/s12879-020-05648-6

11. Cheryl Cohen, Asad Ali, Sudha Basnet, Quique Bassat, W Abdullah Brooks, Malinee Chittaganpitch, Marcela Echavarria, Rodrigo A Fasce, Doli Goswami, Siddhivinayak Hirve, Nusrat Homaira, Stephen R C Howie, Karen L Kotloff, Najwa Khuri-Bulos, Anand Krishnan, Marilla G Lucero, Socorro Lupisan, Ainara Mira-Iglesias, David P Moore, Cinta Moraleda, Marta Nunes, Histoshi Oshitani, Betty E Owor, Fernando P Polack, Katherine L O’Brien, Zeba A Rasmussen, Barbara A Rath, Vahid Salimi, J Anthony G Scott, Eric A F Simões, Tor A Strand, Donald M Thea, Florette K Treurnicht, Linda C Vaccari, Lay-Myint Yoshida, Heather J Zar, Harry Campbell, Harish Nair, for the Respiratory Virus Global Epidemiology Network. Global burden of acute lower respiratory infection associated with human metapneumovirus in children under 5 years in 2018: a systematic review and modeling study. Lancet Glob Health 2020. Published Online November 26, 2020. DOI: 10.1016/S2214-109X(20)30393-4

12. López N, Garcés-Sánchez M, Panizo MB, de la Cueva IS, Artés MT, Ramos B, Cotarelo M. HPV knowledge and vaccine acceptance among European adolescents and their parents: a systematic literature review. Public Health Rev. 2020 May 14;41:10. doi: 10.1186/s40985-020-00126-5. eCollection 2020. PMID: 32435520

13. López N, Garcés-Sánchez M, Panizo MB, de la Cueva IS, Artés MT, Ramos B, Cotarelo M. Correction to: HPV knowledge and vaccine acceptance among European adolescents and their parents: a systematic literature review. Public Health Rev. 2020 Jul 21;41:20. doi: 10.1186/s40985-020-00130-9. eCollection 2020. PMID: 32699653 

1. Klein NP, Abu-Elyazeed R, Povey M, Macias Parra M, Diez-Domingo J, Ahonen A, Korhonen T, Tinoco JC, Weiner L, Marshall GS, Silas PE, Sarpong KO, Ramsey KP, Fling JA, Speicher D, Campos M, Munjal I, Peltier C, Vesikari T, Baccarini C, Caplanusi A, Gillard P, Carryn S, Henry O. Immunogenicity and Safety of a Measles-Mumps-Rubella Vaccine Administered as a First Dose to Children Aged 12 to 15 Months: A Phase III, Randomized, Noninferiority, Lot-to-Lot Consistency Study. J Pediatric Infect Dis Soc. 2019 Mar 8. pii: piz010. doi: 10.1093/jpids/piz010. 

2. Trushakova S, Kisteneva L, Guglieri-López B, Mukasheva E, Kruzhkova I, Mira-Iglesias A, Krasnoslobodtsev K, Morozova E, Kolobukhina L, Puig-Barberà J, Burtseva E. Epidemiology of influenza in pregnant women hospitalized with respiratory illness in Moscow, 2012/2013-2015/2016: a hospital-based active surveillance study. BMC Pregnancy Childbirth. 2019 Feb 15;19(1):72. doi: 10.1186/s12884-019-2192-z.

3. Alguacil-Ramos AM, Portero-Alonso A, Pastor-Villalba E, Muelas-Tirado J, Díez-Domingo J, Sanchis-Ferrer A, Lluch-Rodrigo JA. Rapid assessment of enhanced safety surveillance for influenza vaccine. Public Health. 2019 Mar;168:137-141. doi: 10.1016/j.puhe.2018.12.013. Epub 2019 Feb 13.

4. López-Fauqued M, Campora L, Delannois F, El Idrissi M, Oostvogels L, De Looze FJ, Diez-Domingo J, Heineman TC, Lal H, McElhaney JE, McNeil SA, Yeo W, Tavares-Da-Silva F; ZOE-50/70 Study Group. Safety profile of the adjuvanted recombinant zoster vaccine: Pooled analysis of two large randomised phase 3 trials. Vaccine. 2019 Mar 29. pii: S0264-410X(19)30377-9. doi: 10.1016/j.vaccine.2019.03.043.

5. Pepin S, Dupuy M, Borja-Tabora CFC, Montellano M, Bravo L, Santos J, de Castro JA, Rivera-Medina DM, Cutland C, Ariza M, Diez-Domingo J, Gonzalez CD, Martinón-Torres F, Papadopoulou-Alataki E, Theodoriadou M, Kazek-Duret MP, Gurunathan S, De Bruijn I; GQM05 Study Group. Efficacy, immunogenicity, and safety of a quadrivalent inactivated influenza vaccine in children aged 6-35 months: A multi-season randomised placebo-controlled trial in the Northern and Southern Hemispheres. Vaccine. 2019 Mar 22;37(13):1876-1884. doi: 10.1016/j.vaccine.2018.11.074. Epub 2018 Dec 14.

6. Martinón-Torres F, Diez-Domingo J, Feroldi E, Jordanov E, B’Chir S, Da Costa X. Evaluation of a Hexavalent-Pentavalent-Hexavalent Infant Primary Vaccination Series Followed by a Pentavalent Booster Vaccine in Healthy Infants and Toddlers. Pediatr Infect Dis J. 2019 Mar;38(3):317-322. doi: 10.1097/INF.0000000000002231. 

7. Claeys C, Chandrasekaran V, García-Sicilia J, Prymula R, Díez-Domingo J, Brzostek J, Marès-Bermúdez J, Martinón-Torres F, Pollard AJ, Ruzkova R, Carmona Martinez A, Ulied A, Miranda Valdivieso M, Faust SN, Snape MD, Friel D, Ollinger T, Soni J, Schuind A, Li P, Innis BL, Jain VK. Anamnestic Immune Response and Safety of an Inactivated Quadrivalent Influenza Vaccine in Primed Versus Vaccine-Naïve Children. Pediatr Infect Dis J. 2019 Feb;38(2):203-210. doi: 10.1097/INF.0000000000002217.

8. Díez-Domingo J, Garcés-Sánchez M, Giménez-Sánchez F, Colomina-Rodríguez J, Martinón-Torres F. What have we learnt about rotavirus in Spain in the last 10 years? An Pediatr (Barc). 2019 Apr 7. pii: S1695-4033(19)30076-1. doi: 10.1016/j.anpedi.2019.01.024.

9.Víctor Baselga-Moreno, Svetlana Trushakova, Shelly McNeil, Anna Sominina, Marta C. Nunes, Anca Draganescu, Serhat Unal, Parvaiz Koul, Jan Kyncl, Tao Zhang, Ainagul Kuatbayeva, Afif Ben-Salah, Elena Burtseva, Joan Puig-Barberà, Javier Díez-Domingo and for the Global Influenza Hospital Surveillance Network (GIHSN). Influenza epidemiology and influenza vaccine effectiveness during the 2016–2017 season in the Global Influenza Hospital Surveillance Network (GIHSN). BMC Public Health (2019) 19:487 https://doi.org/10.1186/s12889-019-6713-5.

10. Joan Puig-Barberà, Ainara Mira-Iglesias, Elena Burtseva, Benjamin J. Cowling, Unal Serhat, Guillermo Miguel Ruiz-Palacios, Odile Launay, Jan Kyncl, Parvaiz Koul, Marilda M. Siqueira, Anna Sominina and on behalf of the Global Influenza Hospital Surveillance Network. Influenza epidemiology and influenza vaccine effectiveness during the 2015–2016 season: results from the Global Influenza Hospital Surveillance Network. MC Infectious Diseases201919:415. https://doi.org/10.1186/s12879-019-4017-0

11. Orrico-Sánchez A, López-Lacort M, Muñoz-Quiles C, Martinez-Beneito MA, Díez-Domingo J. Letter to the editor regarding «Rotavirus infection beyond the gut». Infect Drug Resist. 2019 Mar 28;12:707-708. doi: 10.2147/IDR.S202716. eCollection 2019.

12. Oostvogels L, Heineman TC, Johnson RW, Levin MJ, McElhaney JE, Van den Steen P, Zahaf T, Dagnew AF, Chlibek R, Diez-Domingo J, Gorfinkel IS, Hervé C, Hwang SJ, Ikematsu H, Kalema G, Lal H, McNeil SA, Mrkvan T, Pauksens K, Smetana J, Watanabe D, Weckx LY, Cunningham AL. Medical conditions at enrollment do not impact efficacy and safety of the adjuvanted recombinant zoster vaccine: a pooled post-hoc analysis of two parallel randomized trials. Hum Vaccin Immunother. 2019 Jun 28:1-8. doi: 10.1080/21645515.2019.1627818. [Epub ahead of print] PMID: 31216205

13. Danier J, Rivera L, Claeys C, Dbaibo G, Jain VK, Kosalaraksa P, Woo W, Yanni E, Zaman K, Acosta B, Amanullah A, Ariza M, Luisa Arroba Basanta M, Bavdekar A, Carmona A, Cousin L, Diaz A, Diez-Domingo J, Cagri Dinleyici E, Faust SN, Garcia-Sicilia J, Gomez-Go GD, Antionette Gonzales L, Hacimustafaoglu M, Hughes SM, Izu A, Jackowska T, Kant S, Lucero M, Mares Bermudez J, Martinón-Torres F, Montellano M, Prymula R, Puthanakit T, Ruzkova R, Sadowska-Krawczenko I, Soni J, Szymanski H, Ulied A, Schuind A, Innis BL; Flu4VEC Study Group.Clinical Presentation of Influenza in Children 6 to 35 Months of Age: Findings From a Randomized Clinical Trial of Inactivated Quadrivalent Influenza Vaccine. Pediatr Infect Dis J. 2019 Aug;38(8):866-872. doi: 10.1097/INF.0000000000002387.

14.  Ainara Mira-Iglesias, F Xavier López-Labrador, Víctor Baselga-Moreno, Miguel Tortajada-Girbés, Juan Mollar-Maseres, Mario Carballido-Fernández, Germán Schwarz-Chavarri, Joan Puig-Barberà, Javier Díez-Domingo, on behalf of the Valencia Hospital Network for the Study of Influenza and Respiratory Viruses Disease. Influenza vaccine effectiveness against laboratory-confirmed influenza in hospitalised adults aged 60 years or older, Valencia Region, Spain, 2017/18 influenza season. Euro Surveill. 2019;24(31):pii=1800461. https://doi.org/10.2807/1560-7917.ES.2019.24.31.1800461

15. Sastre-Cantón M, Pérez-Vilar S, Vilata-Corell JJ, Díez-Domingo J. Prevalence of oral human papillomavirus infection among university students in Valencia, Spain. Vaccine. 2019 Sep 9. pii: S0264-410X(19)31132-6. doi: 10.1016/j.vaccine.2019.08.058. [Epub ahead of print]

16. Dbaibo G, Amanullah A, Claeys C, Izu A, Jain VK, Kosalaraksa P, Rivera L6, Soni J, Yanni E, Zaman K, Acosta B, Ariza M, Arroba Basanta ML, Bavdekar A, Carmona A, Cousin L, Danier J, Diaz A, Diez-Domingo J, Dinleyici EC, Faust SN, Garcia-Sicilia J, Gomez-Go GD, Gonzales MLA, Hacimustafaoglu M, Hughes SM, Jackowska T, Kant S, Lucero M, Mares Bermudez J, Martinón-Torres F, Montellano M, Prymula R, Puthanakit T, Ruzkova R, Sadowska-Krawczenko I, Szymanski H, Ulied A, Woo W, Schuind A, Innis BL; Flu4VEC Study Group. Quadrivalent Influenza Vaccine Prevents Illness and Reduces Healthcare Utilization Across Diverse Geographic Regions During Five Influenza Seasons: A Randomized Clinical Trial. Pediatr Infect Dis J. 2019 Nov 5. doi: 10.1097/INF.0000000000002504.

17. Christensen H, Al-Janabi H, Levy P, Postma MJ, Bloom DE, Landa P, Damm O, Salisbury DM, Diez-Domingo J, Towse AK, Lorgelly PK, Shah KK, Hernandez-Villafuerte K, Smith V, Glennie L, Wright C, York L, Farkouh R. Economic evaluation of meningococcal vaccines: considerations for the future. Eur J Health Econ. 2019 Nov 21. doi: 10.1007/s10198-019-01129-z
 

18. i-CONSENT Consortium. Special Issue 1/2019 on Informed Consent. DOI: 10.15168/2284-4503-20191S

19. Leitz G, Hu P, Appiani C, Li Q, Mitha E, Garces-Sanchez M, Gupta R. Safety and Efficacy of Low-dose Domperidone for Treating Nausea and Vomiting Due to Acute Gastroenteritis in Children. J Pediatr Gastroenterol Nutr. 2019 Oct;69(4):425-430. doi: 10.1097/MPG.0000000000002409. PMID: 31181017 

20. Moreno-Pérez D, Álvarez García FJ, Álvarez Aldeán J, Cilleruelo Ortega MJ, Garcés Sánchez M, García Sánchez N, Hernández Merino Á, Méndez Hernández M, Merino Moína M, Montesdeoca Melián A, Ruiz-Contreras J; en representación del Comité Asesor de Vacunas de la Asociación Española de Pediatría (CAV-AEP). Immunisation schedule of the Spanish Association of Paediatrics: 2019 recommendations. An Pediatr (Barc). 2019 Jan;90(1):56.e1-56.e9. doi: 10.1016/j.anpedi.2018.10.006. PMID: 30609975 

1. Falup-Pecurariu OG, Diez-Domingo J, Esposito S, Finn A, Rodrigues F, Spoulou V, et al. Clinical and laboratory features of children with community-acquired pneumonia are associated with distinct radiographic presentations. European journal of pediatrics. 2018.

2. Guillard-Maure C, Elango V, Black S, Perez-Vilar S, Castro JL, Bravo-Alcantara P, et al. Operational lessons learned in conducting a multi-country collaboration for vaccine safety signal verification and hypothesis testing: The global vaccine safety multi country collaboration initiative. Vaccine. 2018;36(3):355-62.

3. Mira-Iglesias A, Xavier Lopez-Labrador F, Guglieri-Lopez B, Tortajada-Girbes M, Baselga-Moreno V, Cano L, et al. Influenza vaccine effectiveness in preventing hospitalisation of individuals 60 years of age and over with laboratory-confirmed influenza, Valencia Region, Spain, influenza season 2016/17. Eurosurveillance. 2018;23(8):7-15.

4. Munoz-Quiles C, Lopez-Lacort M, Diez-Domingo J. Risk and impact of herpes zoster among COPD patients: a population-based study, 2009-2014. Bmc Infectious Diseases. 2018;18.

5. Munoz-Quiles C, Lopez-Lacort M, Orrico-Sanchez A, Diez-Domingo J.Impact of postherpetic neuralgia: A six year population-based analysis on people aged 50 years or older. The Journal of infection. 2018.

6. Munoz-Quiles C, Lopez-Lacort M, Orrico-Sanchez A, Diez-Domingo J. Letter to the editor regarding «The role of age-sex interaction in the development of post-herpetic neuralgia». Human Vaccines & Immunotherapeutics. 2018;14(4):906-8.

7. Orrico-Sanchez A, Lopez-Lacort M, Munoz-Quiles C, Diez-Domingo J. Lack of impact of rotavirus vaccines on seizure-related hospitalizations in children under 5years old in Spain. Human vaccines & immunotherapeutics. 2018:1-5.

8. Perez-Vilar S, Weibel D, Sturkenboom M, Black S, Maure C, Castro JL, et al. Enhancing global vaccine pharmacovigilance: Proof-of-concept study on aseptic meningitis and immune thrombocytopenic purpura following measles-mumps containing vaccination. Vaccine. 2018;36(3):347-54.

9. Puig-Barberà J, Mira-Iglesias A, Tortajada-Girbés M, López-Labrador FX, Librero-López J, Díez-Domingo J, Carballido-Fernández M, Carratalá-Munuera C, Correcher-Medina P, Gil-Guillén V, Limón-Ramírez R, Mollar-Maseres J, Otero-Reigada MC, Schwarz-Chavarri G. Waning protection of influenza vaccination during four influenza seasons, 2011/2012 to 2014/2015. Vaccine. 2017 Oct 13;35(43):5799-5807. doi: 10.1016/j.vaccine.2017.09.035.

10. Tom De Smedt, Elizabeth Merrall, Denis Macina, Silvia Perez-Vilar, Nick Andrews, Kaatje Bollaerts. Bias due to differential and non-differential disease- and exposure misclassification in studies of vaccine effectiveness. PLoS One. 2018 Jun 15;13(6):e0199180. doi: 10.1371/journal.pone.0199180. eCollection 2018.

11. Martinón-Torres F, Diez-Domingo J, Feroldi E, Jordanov E, B’Chir S, Da Costa X. Evaluation of a Hexavalent-Pentavalent-Hexavalent Infant Primary Vaccination Series Followed by a Pentavalent Booster Vaccine in Healthy Infants and Toddlers. Pediatr Infect Dis J. 2018 Nov 7. doi: 10.1097/INF.0000000000002231

12. Pepin S, Dupuy M, Borja-Tabora CFC, Montellano M, Bravo L, Santos J, de Castro JA, Rivera-Medina DM, Cutland C, Ariza M, Diez-Domingo J, Gonzalez CD, Martinón-Torres F, Papadopoulou-Alataki E, Theodoriadou M, Kazek-Duret MP, Gurunathan S, De Bruijn I; GQM05 Study Group. Efficacy, immunogenicity, and safety of a quadrivalent inactivated influenza vaccines in children aged 6-35 month: A multi season randomised placebo-controlled trial in the Northern and Southern Hemispheres. Vaccine. 2018 Dec 14. pii: S0264-410X(18)31637-2. doi: 10.1016/j.vaccine.2018.11.074.

13. Ortiz de Lejarazu R, Díez Domingo J, Gil de Miguel A, Martinón Torres F, Guzmán Quilo C, Guillén JM, Piedrafita B, Redondo Marguello E. Description of Influenza B in seasonal epidemics in Spain. Rev Esp Quimioter. 2018 Dec;31(6):511-519. Epub 2018 Nov 5.

14. Moreno-Pérez D, Álvarez García FJ, Álvarez Aldeán J, Cilleruelo Ortega MJ, Garcés Sánchez M, García Sánchez N, Hernández Merino Á, Méndez Hernández M, Merino Moína M, Montesdeoca Melián A, Ruiz-Contreras J; en representación del Comité Asesor de Vacunas de la Asociación Española de Pediatría (CAV-AEP). Immunisation schedule of the Spanish Association of Paediatrics: 2018 recommendations. An Pediatr (Barc). 2018 Jan;88(1):53.e1-53.e9. doi: 10.1016/j.anpedi.2017.10.001. PMID: 29301718 

1. Diez-Domingo J, Sanchez-Alonso V, Villanueva R-J, Acedo L, Morano J-A, Villanueva-Oller J. Random Network Models to Predict the Long-Term Impact of HPV Vaccination on Genital Warts. Viruses-Basel. 2017;9(10).

2. Iro MA, Snape MD, Voysey M, Jawad S, Finn A, Heath PT, et al. Persistence of bactericidal antibodies following, booster vaccination with 4CMenB at 12, 18 or 24 months and immunogenicity of a fifth dose administered at 4 years of age-a phase 3 extension to a randomised controlled trial (vol 35, pg 395, 2017). Vaccine. 2017;35(24):3279-.

3. Iro MA, Snape MD, Voysey M, Jawad S, Finn A, Heath PT, et al. Persistence of bactericidal antibodies following booster vaccination with 4CMenB at 12, 18 or 24 months and immunogenicity of a fifth dose administered at 4 years of age-a phase 3 extension to a randomised controlled trial. Vaccine. 2017;35(2):395-402.

4. Munoz-Quiles C, Lopez-Lacort M, Javier Ampudia-Blasco F, Diez-Domingo J. Risk and impact of herpes zoster on patients with diabetes: A population-based study, 2009-2014. Human Vaccines & Immunotherapeutics. 2017;13(11):2606-11.

5. Navarro-Illana E, Lopez-Lacort M, Navarro-Illana P, Jose Vilata J, Diez-Domingo J. Effectiveness of HPV vaccines against genital warts in women from Valencia, Spain. Vaccine. 2017;35(25):3342-6.

6. Navarro-Illana P, Navarro-Illana E, Vila-Candel R, Diez-Domingo J.Drivers for human papillomavirus vaccination in Valencia (Spain). Gaceta sanitaria. 2017.

7. Orrico-Sanchez A, Lopez-Lacort M, Perez-Vilar S, Diez-Domingo J. Long-term impact of self-financed rotavirus vaccines on rotavirus-associated hospitalizations and costs in the Valencia Region, Spain. Bmc Infectious Diseases. 2017;17.

8. Perez-Breva L, Abad-Torreblanca R, Angel Martinez-Beneito M, Puig-Barbera J, Aleman-Sanchez S, Morant-Talamante N, et al. Seroprevalence of antibodies against serogroup C meningococci in the region of Valencia, Spain: Impact of meningococcal C conjugate vaccination. Vaccine. 2017;35(22):2949-54.

9. Puig-Barbera J, Guglieri-Lopez B, Tortajada-Girbes M, Xavier Lopez-Labrador F, Carballido-Fernandez M, Mollar-Maseres J, et al. Low influenza vaccine effectiveness and the effect of previous vaccination in preventing admission with A(H1N1)pdm09 or B/Victoria-Lineage in patients 60 years old or older during the 2015/2016 influenza season. Vaccine. 2017;35(52):7331-8.

10. Sadarangani M, Sell T, Iro MA, Snape MD, Voysey M, Finn A, et al. Persistence of immunity after vaccination with a capsular group B meningococcal vaccine in 3 different toddler schedules. Canadian Medical Association Journal. 2017;189(41):E1276-E85.

11. Youngster I, Avorn J, Belleudi V, Cantarutti A, Diez-Domingo J, Kirchmayer U, et al. Antibiotic Use in Children – A Cross-National Analysis of 6 Countries. Journal of Pediatrics. 2017;182:239-44.

12. Rondy M, Launay O, Castilla J, Costanzo S, Puig-Barberà J, Gefenaite G, Larrauri A, Rizzo C, Pitigoi D, Syrjänen RK, Machado A, Kurecic Filipovic S, Krisztina Horvath J, Paradowska-Stankiewicz I, Marbus S; InNHOVE/I-MOVE+working group, Moren A. Repeated seasonal influenza vaccination among elderly in Europe: Effects on laboratory confirmed hospitalised influenza. Vaccine. 2017 Aug 3;35(34):4298-4306. doi: 10.1016/j.vaccine.2017.06.088. Epub 2017 Jul 11.

13. Puig-Barberà J, Guglieri-López B, Tortajada-Girbés M, López-Labrador FX, Carballido-Fernández M, Mollar-Maseres J, Schwarz-Chavarri G, Baselga-Moreno V, Mira-Iglesias A, Díez-Domingo J; Valencia Hospital Network for the Study of Influenza, Respiratory Viruses Disease. Low influenza vaccine effectiveness and the effect of previous vaccination in preventing admission with A(H1N1)pdm09 or B/Victoria-Lineage in patients 60 years old or older during the 2015/2016 influenza season. Vaccine. 2017 Dec 19;35(52):7331-7338. doi: 10.1016/j.vaccine.2017.10.100. Epub 2017 Nov 8.

14. Alejandro Orrico, Lucía Martí-Prats, María J. Cano-Cebrián, Luis Granero, Ana Polache and Teodoro Zornoz. Pre-Clinical Studies with D-Penicillamine as a Novel Pharmacological Strategy to Treat Alcoholism: Updated Evidences. Front. Behav. Neurosci., 07 March 2017 | https://doi.org/10.3389/fnbeh.2017.00037

15. Marshall HS, Richmond PC, Beeslaar J, Jiang Q, Jansen KU, Garcés-Sánchez M, Martinón-Torres F, Szenborn L, Wysocki J, Eiden J, Harris SL, Jones TR, Lee SS, Perez JL; 6108A12001 Study Investigators. Meningococcal serogroup B-specific responses after vaccination with bivalent rLP2086: 4 year follow-up of a randomised, single-blind, placebo-controlled, phase 2 trial. Lancet Infect Dis. 2017 Jan;17(1):58-67. doi: 10.1016/S1473-3099(16)30314-0. Epub 2016 Oct 11. PMID: 27745812 

1. Munoz-Quiles C, Lopez-Lacort M, Ubeda-Sansano I, Aleman-Sanchez S, Perez-Vilar S, Puig-Barbera J, et al. Population-based Analysis of Bronchiolitis Epidemiology in Valencia, Spain. Pediatr Infect Dis J. 2016;35(3):275-80.
 
2. Puig-Barbera J, Natividad-Sancho A, Trushakova S, Sominina A, Pisareva M, Ciblak MA, et al. Epidemiology of Hospital Admissions with Influenza during the 2013/2014 Northern Hemisphere Influenza Season: Results from the Global Influenza Hospital Surveillance Network. PLoS One. 2016;11(5):e0154970.
 
3. Qin Y, Zhang Y, Wu P, Feng S, Zheng J, Yang P, et al. Influenza vaccine effectiveness in preventing hospitalization among Beijing residents in China, 2013-15. Vaccine. 2016.
 
1. Aristegui Fernandez J, Diez-Domingo J, Mares Bermudez J, Martinon Torres F. [Vaccination against hepatitis B. Impact of vaccination programmes after 20 years of use in Spain. Is it time for a change?]. Enferm Infecc Microbiol Clin. 2015;33(2):113-8.
 
2. Breva LP, Domingo JD, Martinez Beneito MA, Barbera JP. Vaccine coverage estimation using a computerized vaccination registry with potential underreporting and a seroprevalence study. Vaccine. 2015;33(18):2183-8.
 
3. Caballero-Perez P, Tuells J, Rementeria J, Nolasco A, Navarro-Lopez V, Aristegui J. [Acceptability of the HPV vaccine among Spanish university students in the pre-vaccine era: a cross-sectional study]. Rev Esp Quimioter. 2015;28(1):21-8.
 
4. Diez-Domingo J, Baldo JM, Planelles-Catarino MV, Garces-Sanchez M, Ubeda I, Jubert-Rosich A, et al. Phase II, randomized, open, controlled study of AS03-adjuvanted H5N1 pre-pandemic influenza vaccine in children aged 3 to 9 years: follow-up of safety and immunogenicity persistence at 24 months post-vaccination. Influenza Other Respir Viruses. 2015;9(2):68-77.
 
 
6. Garces-Sanchez M, Renales-Toboso M, Boveda-Garcia M, Diez-Domingo J. [Measles, mumps, and rubella vaccine. Resurgence of measles in Europe]. Enferm Infecc Microbiol Clin. 2015;33(10):673-8.
 
7. Lal H, Cunningham AL, Godeaux O, Chlibek R, Diez-Domingo J, Hwang SJ, et al. Efficacy of an adjuvanted herpes zoster subunit vaccine in older adults. N Engl J Med. 2015;372(22):2087-96.
 
8. Navarro-Illana P, Caballero P, Tuells J, Puig-Barbera J, Diez-Domingo J. [Acceptability of human papillomavirus vaccine in mothers from Valencia (Spain)]. An Pediatr (Barc). 2015;83(5):318-27.
 
9. Perez-Vilar S, Diez-Domingo J, Lopez-Lacort M, Martinez-Ubeda S, Martinez-Beneito MA. Effectiveness of rotavirus vaccines, licensed but not funded, against rotavirus hospitalizations in the Valencia Region, Spain. BMC Infect Dis. 2015;15(1):811.
 
10. Perez-Vilar S, Diez-Domingo J, Puig-Barbera J, Gil-Prieto R, Romio S. Intussusception following rotavirus vaccination in the Valencia Region, Spain. Hum Vaccin Immunother. 2015;11(7):1848-52.
 
11. Puig-Barbera J, Mira-Iglesias A, Tortajada-Girbes M, Lopez-Labrador F, Belenguer-Varea A, Carballido-Fernandez M, et al. Effectiveness of influenza vaccination programme in preventing hospital admissions, Valencia, 2014/15 early results. Euro Surveill. 2015;20(8).
 
12. Puig-Barbera J, Tormos A, Trushakova S, Sominina A, Pisareva M, Ciblak MA, et al. The Global Influenza Hospital Surveillance Network (GIHSN): A new platform to describe the epidemiology of severe influenza. Influenza Other Respir Viruses. 2015.
 
13. Rondy M, Launay O, Puig-Barbera J, Gefenaite G, Castilla J, de Gaetano Donati K, et al. 2012/13 influenza vaccine effectiveness against hospitalised influenza A(H1N1)pdm09, A(H3N2) and B: estimates from a European network of hospitals. Euro Surveill. 2015;20(2).
 
14. Vesikari T, Brodszki N, van Damme P, Diez-Domingo J, Icardi G, Petersen LK, et al. A Randomized, Double-Blind, Phase III Study of the Immunogenicity and Safety of a 9-Valent Human Papillomavirus L1 Virus-Like Particle Vaccine (V503) Versus Gardasil(R) in 9-15-Year-Old Girls. Pediatr Infect Dis J. 2015;34(9):992-8.
 
15. Vesikari T, Østergaard L, Diez-Domingo J, Wysocki J, Flodmark C-E, Beeslaar J, et al. Meningococcal Serogroup B Bivalent rLP2086 Vaccine Elicits Broad and Robust Serum Bactericidal Responses in Healthy Adolescents. J Pediatric Infect Dis Soc. 2015.
 
16.

S Pérez-Vilar,  J Díez-Domingo, J Gomar-Fayos, E Pastor-Villalba, M Sastre-Cantón, J Puig-Barberà. Post-licensure passive safety surveillance of rotavirus vaccines: reporting sensitivity for intussusception. An Pediatr (Barc) actions Search in PubMed Search in NLM Catalog. Add to Search. 2014 Aug;81(2):77-85. doi: 10.1016/j.anpedi.2013.10.027. Epub 2013 Nov 17.

1. Martinon-Torres F, Gimenez-Sanchez F, Bernaola-Iturbe E, Diez-Domingo J, Jiang Q, Perez JL. A randomized, phase 1/2 trial of the safety, tolerability, and immunogenicity of bivalent rLP2086 meningococcal B vaccine in healthy infants. Vaccine. 2014 Sep 8;32(40):5206-11

2. Navarro-Illana P, Aznar J, Diez-Domingo J. Ethical considerations of universal vaccination against human papilloma virus. BMC Med Ethics. 2014;15:29.

3. Navarro-Illana P, Diez-Domingo J, Navarro-Illana E, Tuells J, Aleman S, Puig-Barbera J. «Knowledge and attitudes of spanish adolescent girls towards human papillomavirus infection: where to intervene to improve vaccination coverage». BMC Public Health. 2014;14(1):490.

4. Pérez-Breva L, Villanueva RJ, Villanueva-Oller J, Acedo L, Santonja F, Moraño JA, et al. Optimizing strategies for meningococcal C disease vaccination in Valencia (Spain). BMC Infect Dis. 2014;14(280).

5. Puig-Barbera J, Garcia-de-Lomas J, Diez-Domingo J, Arnedo-Pena A, Ruiz-Garcia M, Limon-Ramirez R, et al, Valencia Hospital Network for the Study of I, Respiratory Virus D. Influenza vaccine effectiveness in preventing influenza A(H3N2)-related hospitalizations in adults targeted for vaccination by type of vaccine: a hospital-based test-negative study, 2011-2012 A(H3N2) predominant influenza season, Valencia, Spain. PLoS One. 2014;9(11):e112294.
 

6. Puig-Barbera J, Natividad-Sancho A, Calabuig-Perez J, Lluch-Rodrigo JA, Pastor-Villalba E, Martinez-Ubeda S, et al. Intradermal and virosomal influenza vaccines for preventing influenza hospitalization in the elderly during the 2011-2012 influenza season: A comparative effectiveness study using the Valencia health care information system. Vaccine. 2014 Sep 22;32(42):5447-54.

7. Puig-Barbera J, Natividad-Sancho A, Launay O, Burtseva E, Ciblak MA, Tormos A, et al. 2012-2013 Seasonal Influenza Vaccine Effectiveness against Influenza Hospitalizations: Results from the Global Influenza Hospital Surveillance Network. PLoS One. 2014;9(6):e100497.

8. Puig-Barbera J, Tormos A, Sominina A, Burtseva E, Launay O, Ciblak MA, et al. First-year results of the Global Influenza Hospital Surveillance Network: 2012-2013 Northern hemisphere influenza season. BMC Public Health. 2014 Jun 5;14(1):564.

9. Rodriguez-Galan MA, Perez-Vilar S, Diez-Domingo J, Tuells J, Gomar-Fayos J, Morales-Olivas F, et al. [Adverse reactions to human papillomavirus vaccine in the Valencian Community (2007-2011).]. Anales de Pediatria. 2014 Feb 26.

10.  Tuells J. [The public health in historical perspective.]. Gac Sanit. 2014;28:87-8. Spanish.

11.  van der Velden MV, Fritz R, Pöllabauer EM, Portsmouth D, Howard MK, Kreil TR, et al.uells J. Safety and immunogenicity of a vero cell culture-derived whole-virus influenza A(H5N1) vaccine in a pediatric population. J Infect Dis. 2014 Jan 1;209(1):12-23 

1. Diez-Domingo J, Gurtman A, Bernaola E, Gimenez-Sanchez F, Martinon-Torres F, Pineda-Solas V, et al. Evaluation of 13-valent pneumococcal conjugate vaccine and concomitant meningococcal group C conjugate vaccine in healthy infants and toddlers in Spain. Vaccine. 2013 Nov 4;31(46):5486-94

2. Dodd CN, Romio SA, Black S, Vellozzi C, Andrews N, Sturkenboom M,  et al. International collaboration to assess the risk of Guillain Barré Syndrome following Influenza A (H1N1) 2009 monovalent vaccines. Vaccine. 2013 Sep 13;31(40):4448-58

3. Lopez-Gigosos R, Campins M, Calvo MJ, Perez-Hoyos S, Diez-Domingo J, Salleras L, et al. Effectiveness of the WC/rBS oral cholera vaccine in the prevention of traveler’s diarrhea: A prospective cohort study. Hum Vaccin Immunother. 2013 Jan 16;9(3).

4. Morant-Talamante N, Diez-Domingo J, Martínez-Úbeda S, Puig-Barberá J, Alemán-Sánchez S, Pérez-Breva L. Herpes zoster surveillance using electronic databases in the Valencian Community (Spain). BMC Infect Dis. 2013 Oct 5;13(1):463.

5. Navarro López V, Hernández Belmonte A, Hernández Ros R, Tuells J. [Patient with human immunodeficiency virus infection and ulcerative    maculopapular skin lesions]. Med Clin (Barc). 2013 Oct 5;141(7):e13. Spanish

6. Pérez-Vilar S, Gutiérrez-Gimeno MV, Rodríguez-Galán MA, Díez-Domingo J, Puig-Barberà J, Gomar-Fayos J, et al. [Suspected adverse events to measles, mumps and rubella vaccine reported to the Community of Valencia Pharmacovigilance Centre]. An Pediatr (Barc). 2013 May;78(5):297-302

7.  Puig-Barberà J, Natividad-Sancho A, Calabuig-Pérez J, Lluch-Rodrigo JA, Pastor-Villalba E, Martínez-Úbeda S, et al. MF59-adjuvanted and virosomal influenza vaccines for preventing influenza hospitalization in older people: Comparative effectiveness using the Valencia health care information system. Vaccine. 2013 Aug 20;31(37):3995-4002

8. Rodgers GL, Esposito S, Principi N, Gutierrez-Brito M, Diez-Domingo J, Pollard AJ, et al. Immune response to 13-valent pneumococcal conjugate vaccine with a reduced dosing schedule. Vaccine. 2013 Oct 1;31(42):4765-74

9. Rondy M, Puig-Barbera J, Launay O, Duval X, Castilla J, Guevara M, et al. 2011-12 Seasonal Influenza Vaccines Effectiveness against Confirmed A(H3N2) Influenza Hospitalisation: Pooled Analysis from a European Network of Hospitals. A Pilot Study. PLoS One. 2013;8(4):e59681.

10. Tuells J. [On the use of the term «vaccinology» in Spanish]. Vacunas. 2013;14(1):1-3. Spanish.

11. Tuells J. [Reasons for an injury compensation programme for adverse vaccine-related events in Spain.]. Med Clin (Barc). 2013 Jun 18;140(12):554-7. Spanish.

12. Tuells J, Caballero P, Nolasco A. Creencias, actitudes e influencia de los medios de comunicación en trabajadores sanitarios españoles durante la gripe pandémica A (H1N1) 2009. Enferm Infecc Microbiol Clin. 2013;31(6):369-74.

13. Tuells J, Duro Torrijos JL. [The fruitless search for the cowpox to perpetuate the vaccine against smallpox]. Vacunas. 2013;14(1):53-57. Spanish.

14. Tuells J, Duro Torrijos JL. El papel del Marqués de Vadillo como propagador de la vacuna en Soria (1801). Vacunas. 2013;14(2):90-95

15. Tuells J, Duro Torrijos JL. [The second expedition of Balmis: revolution and vaccine.]. Gac Med Mex. 2013 May-June;149(3):377-384. Spanish    

16.  Tuells J, Duro Torrijos JL, Chilet Rosell E, Pastor Villalba E, Portero Alonso A, Navarro Ortiz C, et al. [News items on human papillomavirus and its vaccine in the Valencian press (2006-2011).]. Gac Sanit. 2013 Jul-Ago;24(4):374-7. Spanish.

1. Diez-Domingo J, Patrzalek M, Cantarutti L, Arnould B, Meunier J, Soriano-Gabarro M, et al. The impact of childhood acute rotavirus gastroenteritis on the parents’ quality of life: prospective observational study in European primary care medical practices. BMC Pediatr. 2012 May 31;12(1):58.

2. Esposito S, Cohen R, Domingo JD, Pecurariu OF, Greenberg D, Heininger U, et al. Antibiotic Therapy for Pediatric Community-Acquired Pneumonia: Do We Know When, What and For How Long to Treat? Pediatr Infect Dis J. 2012 Mar;31(6)e78-e85

3. Gossger N, Snape MD, Yu LM, Finn A, Bona G, Esposito S, et al. Immunogenicity and tolerability of recombinant serogroup B meningococcal vaccine administered with or without routine infant vaccinations according to different immunization schedules: a randomized controlled trial. JAMA. 2012 Feb 8;307(6):573-82.

4. Martinon-Torres F, Gimenez-Sanchez F, Gurtman A, Bernaola E, Diez-Domingo J, Carmona A, et al. 13-valent Pneumococcal Conjugate Vaccine Given with Meningococcal C Tetanus Toxoid Conjugate and Other Routine Pediatric Vaccinations: Immunogenicity and Safety. Pediatr Infect Dis J. 2012 Apr;31(4):392-9

5. Soriano García E, Platero Sanchis L, Díez Domingo J. Adaptación del calendario de vacunación a los niños inmigrantes. Enferm. pediátr. 2012; 4(1): 2-5

6. Tuells J, Arístegui J. [Vaccinations in the Public Health Law: the 21 immunization schedules and so it goes]. Med Clin (Barc). 2012 Jun 2;139(1):13-5.

7. Tuells J. [The revision process of Francisco Xavier Balmis’ translation of Moreau de la Sarthe’s Historical and Practical Treatise on Vaccines.]. Gac Sanit. 2012 Jul-Aug;26(4):372-5.

1. Acedo L, Moraño JA, Villanueva RJ, Villanueva-Oller J, Díez-Domingo J. Using random networks to study the dynamics of respiratory syncytial virus (RSV) in the Spanish region of Valencia. Mathematical and Computer Modelling. 2011;54(7-8):1650-54.

2. Díez-Domingo J, Baldo JM, Patrzalek M, Pazdiora P, Forster J, Cantarutti L, et al. Primary care-based surveillance to estimate the burden of rotavirus gastroenteritis among children aged less than 5 years in six European countries. Eur J Pediatr. 2011 Feb;170(2):213-22.

3. Giménez-Sánchez F, Kieninger DM, Kueper K, Martinon-Torres F, Bernaola E, Díez-Domingo J, et al. Immunogenicity of a combination vaccine containing diphtheria toxoid, tetanus toxoid, three-component acellular pertussis, hepatitis B, inactivated polio virus, and Haemophilus influenzae type b when given concomitantly with 13-valent pneumococcal conjugate vaccine. Vaccine. 2011 Aug 11;29(35):6042-6048.

4. Picazo JJ, de Arístegui Fernández J, Arteagoitia Axpe JM, Ordóñez DB, Gurrea AB, José XB, et al. Evidencias científicas disponibles sobre la seguridad de las vacunas. Vacunas.12(1):3-34.

5. Puig-Barberá J. 2010-2011 influenza seasonal vaccine, preliminary mid-season effectiveness estimates: reason for concern, confounding or are we following the right track? Euro Surveill. 2011 Mar 17;16(11).

1. Acedo L, Díez-Domingo J, Morano JA, Villanueva RJ. Mathematical modelling of respiratory syncytial virus (RSV): vaccination strategies and budget applications. Epidemiol Infect. 2010 Jun;138(6):853-60.

2. Acedo L, Moraño JA, Díez-Domingo J. Cost analysis of a vaccination strategy for respiratory syncytial virus (RSV) in a network model. Mathematical and Computer Modelling. 2010;52(7-8):1016-22.

3. Cebrián-Cuenca AM, Díez-Domingo J, Rodriguez MS, Puig-Barberá J, Navarro-Perez J. Epidemiology of herpes zoster infection among patients treated in primary care centres in the Valencian community (Spain). BMC Fam Pract. 2010;11:33.

4. Díez-Domingo J, Cantarino MV, Torrenti JM, Sansano MI, Rosich AJ, Merino AH, et al. A randomized, multicenter, open-label clinical trial to assess the immunogenicity of a meningococcal C vaccine booster dose administered to children aged 14 to 18 months. Pediatr Infect Dis J. 2010 Feb;29(2):148-52.

5. Díez-Domingo J, Flores SA, Martin JC, Klopfer SO, Schodel FP, Bhuyan PK. A randomized, multicenter, open-label clinical trial to assess the anamnestic immune response 4 to 8 years after a primary hepatitis B vaccination series. Pediatr Infect Dis J. 2010 Oct;29(10):972-4.

6. Díez-Domingo J, Garces-Sánchez M, Baldo JM, Planelles MV, Ubeda I, JuBert A, et al. Immunogenicity and Safety of H5N1 A/Vietnam/1194/2004 (Clade 1) AS03-adjuvanted prepandemic candidate influenza vaccines in children aged 3 to 9 years: a phase ii, randomized, open, controlled study. Pediatr Infect Dis J. 2010 Jun;29(6):e35-46.

7. Díez-Domingo J, Planelles-Cantarino MV, Baldo-Torrenti JM, Ubeda-Sansano I, Jubert-Rosich A, Puig-Barberá J, et al. Antibody persistence 12 months after a booster dose of meningococcal-C conjugated vaccine in the second year of life. Pediatr Infect Dis J. 2010 Aug;29(8):768-70.

8. Díez-Domingo J, Surinach NL, Alcalde NM, Betegon L, Largeron N, Trichard M. Burden of paediatric Rotavirus Gastroenteritis (RVGE) and potential benefits of a universal Rotavirus vaccination programme with a pentavalent vaccine in Spain. BMC Public Health. 2010;10:469.

9. Díez-Gandía A, Ajenjo MA, Navalon AB, Fernandez RB, Sanz AB, Díez-Domingo J. [Palatability of oral rehydration solutions (ORS) in healthy 6 to 9 year-old children. A multicentre, randomised single blind clinical trial]. An Pediatr (Barc). 2010 Feb;72(2):111-5.

10. Gutierrez-Gimeno MV, Martin-Moreno JM, Díez-Domingo J, Asensi-Botet F, Hernandez-Marco R, Correcher-Medina P, et al. Nosocomial rotavirus gastroenteritis in Spain: a multicenter prospective study. Pediatr Infect Dis J. 2010 Jan;29(1):23-7.

11. Marshall H, Nolan T, Díez Domingo J, Rombo L, Sokal EM, Mares J, et al. Long-term (5-year) antibody persistence following two- and three-dose regimens of a combined hepatitis A and B vaccine in children aged 1-11 years. Vaccine. 2010 Jun 17;28(27):4411-5.

12. Puig-Barberá J, Arnedo-Pena A, Pardo-Serrano F, Tirado-Balaguer MD, Perez-Vilar S, Silvestre-Silvestre E, et al. Effectiveness of seasonal 2008-2009, 2009-2010 and pandemic vaccines, to prevent influenza hospitalizations during the autumn 2009 influenza pandemic wave in Castellon, Spain. A test-negative, hospital-based, case-control study. Vaccine. 2010 Nov 3;28(47):7460-7.

13. Tuells J MPE. Maurice Hilleman (1919-2005), el hombre que inventaba vacunas. Vacunas. 2010;11(1).

14. Tuells J MPE. Mujeres ante la gripe de 1918: la acreditación de las enfermeras. Vacunas. 2010;11(1).

1. Arnedo-Pena A, Puig-Barberá J, Bellido-Blasco JB, Pac-Sa MR, Campos-Cruanes JB, Artero-Sivera A, et al. Risk factors and prevalence of asthma in schoolchildren in Castellon (Spain): a cross-sectional study. Allergol Immunopathol (Madr). 2009 May-Jun;37(3):135-42.

2. Bernaola Iturbe E, Giménez Sánchez F, Baca Cots M, De Juan Martin F, Díez Domingo J, Garces Sánchez M, et al. [Vaccination schedule of the Spanish association of pediatrics: recommendations 2009]. An Pediatr (Barc). 2009 Jan;70(1):72-82.

3. Gutierrez-Gimeno MV. Gastroenteritis aguda por rotavirus. Un problema en nuestros hospitales. Acta Pediatr Esp. 2009 67 (9):443-450

4. Ladhani S, Heath PT, Slack MP, McIntyre PB, Díez-Domingo J, Campos J, et al. Haemophilus influenzae serotype b conjugate vaccine failure in twelve countries with established national childhood immunization programmes. Clin Microbiol Infect. 2010 Jul;16(7):948-54.

5. Monto AS, Ansaldi F, Aspinall R, McElhaney JE, Montano LF, Nichol KL, et al. Influenza control in the 21st century: Optimizing protection of older adults. Vaccine. 2009 Aug 13;27(37):5043-53.

6. Puig-Barberá J, Díez-Domingo J, Pastor-Villalba E, Garcia de Lomas J, Huertas-Zarco I, Perez-Hoyos S. Pertussis in adults with persistent cough: a prospective follow up study in primary care. Procedia in Vaccinology. 2009; 1 (1):73-80

1. Bernaola Iturbe E, Giménez Sánchez F, Baca Cots M, de Juan Martin F, Díez Domingo J, Garces Sánchez M, et al. [Immunization schedule of the Spanish Association of Pediatrics: recommendations 2008]. An Pediatr (Barc). 2008 Jan;68(1):63-9.

2. Bernaola Iturbe E, Giménez Sánchez F, Baca Cots M, de Juan Martin F, Díez Domingo J, Garces Sánchez M, et al. [Criteria for including vaccines in the immunization schedule of the Spanish Association of Pediatrics]. An Pediatr (Barc). 2008 Jan;68(1):58-62.

3. Martinon-Torres F, Bernaola Iturbe E, Giménez Sánchez F, Baca Cots M, de Juan Martin F, Díez Domingo J, et al. [Why are pediatric empyemas on the increase in Spain?]. An Pediatr (Barc). 2008 Feb;68(2):158-64.

4. Pac-Sa MR, Museros-Recatala L, Arnedo-Pena A, Bellido-Blasco JB, Puig-Barberá J, Artero-Sivera A, et al. [Risk factors for symptoms of allergic rhinitis in adolescents in Castellon, Spain]. Rev Panam Salud Publica. 2008 May;23(5):333-40.

1. Arnedo-Pena A, Puig-Barberá J, Aznar-Orenga MA, Ballester-Albiol M, Pardo-Serrano F, Bellido-Blasco JB, et al. Varicella vaccine effectiveness during an outbreak in a partially vaccinated population in Spain. Pediatr Infect Dis J. 2006 Sep;25(9):774-8.

2. Campins Marti M, Díez Domingo J. [Avian influenza: When the vaccine will be ready?]. Med Clin (Barc). 2006 Jun 17;127(3):93-5.

3. Díez Domingo J, Ridao Lopez M, Ubeda Sansano I, Ballester Sanz A. [Incidence and cost of hospitalizations for bronchiolitis and respiratory syncytial virus infections in the autonomous community of Valencia in Spain (2001 and 2002)]. An Pediatr (Barc). 2006 Oct;65(4):325-30.

4. Díez-Domingo J, Martin IO, Sanz AB, Lopez AG, Martinez CC, Boronat CP, et al. Rotavirus gastroenteritis among children under five years of age in Valencia, Spain. Pediatr Infect Dis J. 2006 May;25(5):455-7.

5. Lenne X, Díez Domingo J, Gil A, Ridao M, Lluch JA, Dervaux B. Economic evaluation of varicella vaccination in Spain: results from a dynamic model. Vaccine. 2006 Nov 17;24(47-48):6980-9.

6. Martinon-Torres F, Bernaola Iturbe E, Giménez Sánchez F, Baca Cots M, De Juan Martin F, Díez Domingo J, et al. [Human papillomavirus vaccines: a new challenge for pediatricians]. An Pediatr (Barc). 2006 Nov;65(5):461-9.

7. Pou-Bordoy J, Gene-Badia J, de la Camara-Gonzalez C, Berraondo-Zabalegui I, Puig-Barberá J. [Single management: an illusion without evidence]. Aten Primaria. 2006 Mar 15;37(4):231-4.

8. Puig-Barberá J, Márquez-Calderon S, Vila-Sánchez M. [Cardiac complications of major elective non-cardiac surgery: incidence and risk factors]. Rev Esp Cardiol. 2006 Apr;59(4):329-37.

9. Puig-Barberá J, Márquez-Calderon S. Complicaciones postoperatorias de origen cardiaco en mayores de 40 años: Validación de los índices de Detsky y de Lee: Derivación de un nuevo índice de predicción de riesgo. Valencia. Conselleria de Sanitat. 2006

1. Arnedo Pena A, Puig Barberá J, Pardo Serrano F. [Varicella outbreak in a work center for psychologically handicapped adults]. Med Clin (Barc). 2005 Jun 18;125(3):95-7.

2. Díez-Domingo J, Delgado JD, Ballester A, Baldo JM, Planelles MV, Garces M, et al. Immunogenicity and reactogenicity of a combined adsorbed tetanus toxoid, low dose diphtheria toxoid, five component acellular pertussis and inactivated polio vaccine in six-year-old children. Pediatr Infect Dis J. 2005 Mar;24(3):219-24.

3. Díez-Domingo J, Gil A, San-Martin M, Gonzalez A, Esteban J, Baldo JM, et al. Seroprevalence of varicella among children and adolescents in Valencia, Spain. Reliability of the parent’s reported history and the medical file for identification of potential candidates for vaccination. Hum Vaccin. 2005 Sep-Oct;1(5):204-6.

4. Garces-Sánchez MD, Díez-Domingo J, Ballester Sanz A, Peidro Boronat C, Garcia Lopez M, Anton Crespo V, et al. [Epidemiology of community-acquired pneumonia in children aged less than 5 years old in the Autonomous Community of Valencia (Spain)]. An Pediatr (Barc). 2005 Aug;63(2):125-30.

5. Puig-Barberá J. [Measurement of efficacy of influenza vaccination in elderly individuals. How and why]. Med Clin (Barc). 2005 Nov 19;125(18):695-6.

6. Roberton D, Marshall H, Nolan TM, Sokal E, Díez-Domingo J, Flodmark CE, et al. Reactogenicity and immunogenicity profile of a two-dose combined hepatitis A and B vaccine in 1-11-year-old children. Vaccine. 2005 Oct 17;23(43):5099-105